Cargo Systems Messaging Service
CSMS #42090240 - Food and Drug Administration (FDA) End-Dated and New Center for Drug Evaluation and Research (CDER) Product Codes
The Food and Drug Administration (FDA) will be end-dating two Center for Drug Evaluation and Research (CDER) product codes listed below in 30 days. The end-date will be effective on April 20, 2020.
End-dated Code/Description
60M[][]09/Hydromorphone HCl (Analgesic, Narcotic) 60M[][]25/Hydromorphone Hydrochloride (Analgesic, Narcotic)
Please use product code 60M[][]08, which will have an updated description of Hydromorphone Hydrochloride (Analgesic, Narcotic), instead of the end-dated codes.
The Food and Drug Administration (FDA) has added new Center for Drug Evaluation and Research (CDER) product codes listed below and are available immediately.
New Product Code/Description:
62Z[][]44/Darolutamide (Anti-Neoplastic - Part II) 62Z[][]45/Duvelisib (Anti-Neoplastic - Part II) 62Z[][]46/Encorafenib (Anti-Neoplastic - Part II) 62Z[][]47/Entrectinib (Anti-Neoplastic - Part II) 62Z[][]48/Erdafitinib (Anti-Neoplastic - Part II) 62Z[][]49/Fedratinib Hydrochloride (Anti-Neoplastic - Part II) 62Z[][]50/Ivosidenib (Anti-Neoplastic - Part II) 62Z[][]51/Levoleucovorin (Anti-Neoplastic - Part II) 62Z[][]53/Alimta (Anti-Neoplastic - Part II) 62Z[][]54/Pexidartinib Hydrochloride (Anti-Neoplastic - Part II) 62Z[][]55/Selinexor (Anti-Neoplastic - Part II) 62Z[][]56/Talazoparib Tosylate (Anti-Neoplastic - Part II) 63O[][]10/Lasmiditan Succinate (Antimigraine Agent) 64F[][]27/Netarsudil Dimesylate (Enzyme inhibitor) 64F[][]28/Fostamatinib Disodium (Enzyme inhibitor)
Please send any questions or concerns to the email address for the Product Code Builder Feedback: PCBFeedback@fda.hhs.gov
For assistance with product code identification, the public may also refer to the FDA Product Code Builder.
|